PhenoVista Biosciences

01/13/2026

Our in-house Nanolive system can be used to run several of our most popular assays in a label-free manner, including assessment of cell viability/proliferation, mitochondrial health, and lipid-droplet dynamics.

The platform allows for long-term, live-cell monitoring of cultures with fully integrated, AI-driven, quantitative analysis. This lets us continue to provide high-quality images and data to our clients about the effects of their test articles without the use of labels or dyes.

See examples of Nanolive technology in action here: https://na2.hubs.ly/H02_S4v0
And read more about our assay services here: https://na2.hubs.ly/H02_QRj0

Contact us to discuss how your R&D may benefit from Nanolive!

01/08/2026

Our newest blog post discusses the unique advantages high-content imaging (HCI) offers in driving forward biological and drug-development research.

Check it out here: https://na2.hubs.ly/H02Ws6b0

If you’re interested in discussing how HCI may benefit your R&D projects this year, send us a message or email or contact us through our website!

High-content imaging is a transformative approach in preclinical research, powering breakthroughs in drug discovery and translational science.

01/07/2026

We are starting 2026 with a month-long promotion!

From now until January 30th, get our lowest prices we’ve offered yet on our Ready-2-Go Liver Fibrosis Assay Services.

Get in touch with us ASAP to take advantage of this offer!

12/22/2025

Happy holidays from all of us at PhenoVista!

Thank you to all of our clients who have trusted us with their projects this year. We hope you all have a safe and relaxing end of 2025, and we hope to work with you again next year!

12/18/2025

If you’re in the health supplements, wellness, or nutraceuticals industry, we may be able to help you with the development and marketing of your new products!

We’ve worked with various companies in these fields to assess and characterize products for toxicity and efficacy using cell-based models, as well as to collect data and images for their marketing campaigns.

For an overview of how cell-based assays can help the nutraceuticals industry, see our blog post here: https://na2.hubs.ly/H02HSJM0

Get in touch to discuss how we might be able to help out!

Learn how in vitro assays are contributing to nutraceutical product development and how they can help improve product efficacy.

12/17/2025

There's still time to book a project with us before our prices increase in January!

Our resources in January are already being scheduled, so if you have end-of-year budget to spend and need data quickly, book your project with us ASAP.

Get in touch with us by messaging us or by contacting us through our website:

We’re here to help you along your drug discovery journey. Contact us with your questions about our assay services.

12/16/2025

Reminder about our special, end-of-year pricing for our Ready-2-Go Assay Services!

We are offering new, lower pricing on our Ready-2-Go Neurotoxicity, Neurite Outgrowth, and Lung Fibrosis Assay Services for all projects booked this month.

If you have leftover budget to use before 2026, this is a cost-effective way to get high-quality data quickly.

For more information about our R2G Lung Fibrosis assay, visit: https://na2.hubs.ly/H02lmMx0

For information about our R2G Neurite Outgrowth assay, visit: https://na2.hubs.ly/H02ll0k0

Contact us today to learn more or to submit your test articles!

Our R2G Lung Fibrosis Assay Service uses multiplexed analysis of SMA stress fibers & cell morphology to enable you to choose the best drug candidates.

12/11/2025

New case study alert!

If you’re working in cell/gene therapy, you may be interested in our AAV capabilities. Here, we measure the preferential uptake and transduction of two AAV serotypes in primary, human hepatic stellate cells.

The year is coming to a rapid end, and we are already booking into Q1 of 2026! Get in touch with us ASAP to get your project into our rapidly filling pipeline.

Download a copy of this case study here:

Review a custom project designed to measure AAV transduction efficiency and effect on viability in hepatic stellate cells (HSCs).

12/04/2025

New Ready-2-Go Assay Services promotion!

In addition to our low, bulk pricing on our Ready-2-Go Neurotoxicity and Neurite Outgrowth Assay Services, we are offering a new, low rate for our Ready-2-Go Lung Fibrosis Assay Service for all projects booked this month.

If you have leftover budget to use before 2026, this is a cost-effective way to get high-quality data quickly.

For more information about our R2G Lung Fibrosis assay, visit: https://na2.hubs.ly/H02lgc30

For information about our R2G Neurite Outgrowth assay, visit: https://na2.hubs.ly/H02llDD0

Contact us today to learn more or to submit your test articles!

Our R2G Lung Fibrosis Assay Service uses multiplexed analysis of SMA stress fibers & cell morphology to enable you to choose the best drug candidates.

12/02/2025

Our partnership with Carolina Molecular expands your access to meaningful data in our most popular Ready-2-Go Assay Services – lung and liver fibrosis.

In addition to our usual phenotypic readouts that assess stress-fiber formation and cell morphology, you can also get protein-expression quantification of fibrosis-related targets, including several MMPs, and expression profiling of 40+ fibrosis-related genes.

Learn more about our Fibrosis Assays here: https://na2.hubs.ly/H02k07z0

Contact us today for a full list of targets and to get your project booked before 2026 price increases!

Off-the-shelf and custom fibrosis assay services for evaluating your anti-fibrotic drug candidates. Gain better insights into fibrosis R&D.

11/20/2025

We specialize in high-content imaging, but did you know that we work with many partners to offer our clients access to a wide range of technologies and multi-omic data to supplement their phenotypic assessments?

From suppliers of high-quality cells to services like transcriptomics and proteomics, we can help you answer your most-pressing, R&D questions.

Get in touch to learn more!
And for a list of our partners, visit

PhenoVista Biosciences has partnered with the following companies to expand our assay service offerings.

11/18/2025

We’ve worked with many clients studying neurodegenerative diseases. Take a look at some examples of Parkinson’s disease-relevant assays we have developed and executed.

Download your own copy here: https://hubs.ly/Q03R9WhX0

Contact us to learn more!

Learn about Parkinson's disease (PD) and review examples of phenotypic studies designed to measure aspects of PD-relevant biology.